Indraprastha Medical Corporation Gears Up for Q3 Reveal on 3rd February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

Indraprastha Medical Corporation’s Q3 results FY26 are scheduled to be announced on 3rd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Indraprastha Medical Corporation Q3 Results 2026 Preview

• Indraprastha Medical Corporation’s revenue is expected to be in the range of ₹324.93 crore, a 7.12% YoY decrease. 
• Profit After Tax, or PAT, is projected to fall by 22.62% YoY. 
• Net profit is ₹32.81 crore, up 22.62% YoY 
• EBITDA to fall 21.90%

Indraprastha Medical Corporation Share Performance 

• Over the past six months, Indraprastha Medical Corporation’s share price has fallen by 10.40% to ₹922.00.
• Moreover, over the past year, the stock has decreased by 89.03%.
• Despite this weak short-term performance, Indraprastha Medical Corporation’s stock has delivered a financially sound 681.69% return over the past 5 years.
• As of 3rd February 2026, the stock traded at ₹922.00 per share.

Key Factors to Watch for Indraprastha Medical Corporation Q3 Results FY26 

1. Revenue & Patient Volume Growth: Look at overall hospital revenue and growth in in-patient/out-patient numbers — higher utilisation reflects stronger demand and healthcare service traction.
   
2. Profitability & Margins: Monitor EBITDA and net profit margins, since cost control and pricing power (e.g., tariff increases) directly affect earnings.
   
3. Average Revenue per Bed / Occupancy: Metrics like average revenue per occupied bed (ARPOB) and bed occupancy rates — these show pricing power and operational efficiency in the premium hospital segment.
   
4. Cost & Cash Flow Trends: Watch operating cost trends, working capital and cash generation, especially since hospital businesses are capital-intensive and cash flow matters for expansion.
   
5. Regulatory & Realisation Changes: Impact of tariff changes (like CGHS fee hikes) or reimbursement rate adjustments — these can increase realisations and improve profitability.
   

Final Thoughts

Indraprastha Medical Corporation will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 7.12% revenue growth, a 22.62% fall in PAT, and a 21.90% fall in EBITDA. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here